The Chemours Company
CC
$20.22
-$0.64-3.07%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.55% | 0.43% | 0.02% | 0.60% | -1.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.55% | 0.43% | 0.02% | 0.60% | -1.95% |
| Cost of Revenue | 5.18% | 5.60% | 2.55% | 1.92% | 0.26% |
| Gross Profit | -19.27% | -20.56% | -10.50% | -4.91% | -10.39% |
| SG&A Expenses | -11.46% | -17.50% | 7.55% | 12.95% | 1.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.20% | 2.81% | 2.98% | 3.06% | 0.39% |
| Operating Income | -36.62% | -30.22% | -33.97% | -28.29% | -26.10% |
| Income Before Tax | -908.11% | -358.88% | -652.63% | -453.01% | 108.83% |
| Income Tax Expenses | 330.77% | 197.30% | 553.57% | 603.70% | 127.96% |
| Earnings from Continuing Operations | -3,836.36% | -652.86% | -610.61% | -490.00% | 103.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 50.00% | 50.00% | -- |
| Net Income | -3,836.36% | -652.86% | -628.13% | -498.15% | 103.35% |
| EBIT | -36.62% | -30.22% | -33.97% | -28.29% | -26.10% |
| EBITDA | -15.56% | -9.45% | -17.11% | -14.51% | -15.37% |
| EPS Basic | -3,616.47% | -647.30% | -623.53% | -495.18% | 103.53% |
| Normalized Basic EPS | -80.17% | -69.94% | -68.14% | -59.59% | -51.93% |
| EPS Diluted | -4,676.63% | -673.77% | -662.61% | -509.96% | 102.71% |
| Normalized Diluted EPS | -80.22% | -69.89% | -68.09% | -59.34% | -51.87% |
| Average Basic Shares Outstanding | -1.94% | 3.30% | 3.36% | 3.44% | 3.36% |
| Average Diluted Shares Outstanding | -1.98% | 3.08% | 3.14% | 2.87% | 3.03% |
| Dividend Per Share | -73.75% | -48.75% | -32.50% | -16.25% | 0.00% |
| Payout Ratio | -1.01% | -1.10% | -1.13% | -1.21% | 30.62% |